Results from a large multinational clinical trial (guardian1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy - Lentz, SR; Misgav, M; Ozelo, M (Haemophilia, 2013)
et al.